Related Experiment Video
Updated: Jan 29, 2026

Clinical Practice Protocol of Creative Music Therapy for Preterm Infants and Their Parents in the Neonatal Intensive Care Unit
Published on: January 7, 2020
Prolonged duration of early antibiotic therapy in extremely premature infants
Rachel G Greenberg1, Dhuly Chowdhury2, Nellie I Hansen2
1Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA. rachel.greenberg@duke.edu.
Insights
Prolonged early antibiotic use in extremely premature infants decreased but varied by center. This treatment was not linked to higher death or necrotizing enterocolitis (NEC) rates.
Area of Science:
- Neonatal research
- Pediatric pharmacology
- Infectious disease epidemiology
Background:
- Early antibiotic administration in extremely premature infants is common but may have adverse effects.
- The necessity of prolonged antibiotic use without confirmed infection or necrotizing enterocolitis (NEC) is debated.
- Understanding the prevalence and outcomes of this practice is crucial for optimizing neonatal care.
Purpose of the Study:
- To assess the prevalence of prolonged early antibiotic use in extremely premature infants.
- To evaluate the association between prolonged early antibiotics and adverse outcomes, including death and NEC.
- To examine variations in this practice across different clinical centers and over time.
Main Methods:
- A cohort study included 5730 infants born between 2008-2014 at 13 centers.
- Infants were born between 22-28 weeks gestation and weighed 401-1000 grams.
- Prolonged early antibiotics were defined as ≥5 days of therapy initiated within 72 hours of age; outcomes were assessed using multivariable logistic regression.
Main Results:
- The proportion of infants receiving prolonged early antibiotics ranged from 30-69% across centers and decreased from 49% in 2008 to 35% in 2014.
- Prolonged early antibiotics were not significantly associated with an increased risk of death (aOR 1.17; 95% CI: 0.99-1.40).
- No significant association was found between prolonged early antibiotics and necrotizing enterocolitis (NEC).
Conclusions:
- The use of prolonged early antibiotics in extremely premature infants has declined but shows persistent variation among centers.
- This practice was not significantly associated with increased mortality or NEC in the studied cohort.
- Further research may be needed to establish optimal antibiotic stewardship in neonatal intensive care.
Background:
Prolonged early antibiotics in extremely premature infants may have negative effects. We aimed to assess prevalence and outcomes of provision of prolonged early antibiotics to extremely premature infants in the absence of culture-confirmed infection or NEC.
Methods:
Cohort study of infants from 13 centers born without a major birth defect from 2008-2014 who were 401-1000 grams birth weight, 22-28 weeks gestation, and survived ≥5 days without culture-confirmed infection, NEC, or spontaneous intestinal perforation. We determined the proportion of infants who received prolonged early antibiotics, defined as ≥5 days of antibiotic therapy started at ≤72 h of age, by center and over time. Associations between prolonged early antibiotics and adverse outcomes were assessed using multivariable logistic regression.
Results:
A total of 5730 infants were included. The proportion of infants receiving prolonged early antibiotics varied from 30-69% among centers and declined from 49% in 2008 to 35% in 2014. Prolonged early antibiotics was not significantly associated with death (adjusted odds ratio 1.17 [95% CI: 0.99-1.40], p = 0.07) and was not associated with NEC.
Conclusions:
The proportion of extremely premature infants receiving prolonged early antibiotics decreased, but significant center variation persists. Prolonged early antibiotics were not significantly associated with increased odds of death or NEC.
Related Concept Videos
Antibiotic Selection
Absolute and Local Extreme Values
Gene Therapy
Development of Antibiotic Resistance
Drug Dosing: Infants and Children
Group Therapy

